Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
리윤바이오
Yuseong-gu, Daejeon, South Koreainstagram.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Other
01
Overview
리윤바이오는 난치성 피부질환(특히 아토피 피부염과 가려움증) 및 자가면역질환을 표적으로 하는 저분자 신약 후보물질과 바이오 소재를 개발하는 한국의 바이오 기업이다. 주요 파이프라인은 세포 내 염증신호 조절을 통한 표적 치료제(저분자 화합물)에 집중되어 있으며, 플라보노이드 유도체 기반의 신규 소재(APN Flavo 01)는 국제 화장품 원료집(ICID)에 등재되어 상업화에 성공했다. 현재 의약품 파이프라인은 주로 전임상 단계에 있다.
- Therapeutic areas
- OncologyDermatologyImmunology
- Modalities
- Small moleculeNatural product derivative (flavonoid)Biologic (for cosmetic/dermatology applications)
- Industry
- Biotech
02
Partnerships
None publicly disclosed.
Beyond the preview
Go deeper on 리윤바이오.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 리윤바이오.